The portfolio contains a diverse range of formulations including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids such as cannabidiol (“CBD”), cannabigerol (“CBG”), and tetrahydrocannabinol (“THC”).

The formulary is supported by ongoing consumer, patient, and medical community education and training including https://www.avicanna.com/avicenna-academy. 

The brand is currently available nationwide to patients in medical channels across Canada including MyMedi.ca. RHO Phyto is also accessible through several other medical portals such as The University Health Network (“UHN”) and the Odette Cancer Centre pharmacy of Sunnybrook Health Science Centre, a major hospital group in Canada.